儿科导管市场 - 按产品类型、材料、最终用途 - 全球预测，2024 年 - 2032 年

在导管设计技术创新、微创手术需求不断增长、医疗保健支出增加以及儿科医疗保健意识不断提高的推动下，2024-2032年全球儿科导管市场将以7.1%的复合年增长率增长。

泌尿道感染（UTI）、膀胱输尿管逆流（VUR）和神经性膀胱功能障碍等儿科泌尿系统疾病的盛行率不断增加，是儿科导管市场成长的重要驱动力。

根据 BMC Infectious Drugs 的数据，泌尿道感染是全球第二大流行的传染病，每年影响超过 1.5 亿人。泌尿道感染的特征是尿路细菌感染，需要及时诊断和治疗以预防併发症，通常会使用导尿术采集尿液样本和给药。

同样，由神经系统疾病引起的神经源性膀胱功能障碍需要定期插入导尿管以防止尿潴留和相关併发症。儿科导管的需求不断增长，反映出儿科泌尿科对有效诊断和治疗干预措施的需求不断增加，促使製造商创新和开发客製化的导管解决方案，以满足儿科患者的独特需求。

儿科导管市场根据产品类型、材料、最终用途和地区进行分类。

由于泌尿导管广泛用于诊断和治疗各种儿科泌尿疾病，泌尿导管细分市场将在 2024 年至 2032 年期间获得可观的效益。泌尿导管，包括 Foley 导管、间歇性导管和外置导管，在治疗儿科患者的尿潴留、尿失禁和膀胱功能障碍方面发挥着至关重要的作用。泌尿导管设计的不断创新，例如亲水涂层、抗菌特性和儿科专用尺寸，正在进一步推动扩张。

到 2032 年，由于对门诊手术的偏好日益增加以及对具有成本效益的医疗保健服务模式的日益关注，门诊手术中心 (ASC) 细分市场将占据一定的儿科导管市场份额。 ASC 为儿科导管插入手术提供了便捷高效的环境，能够及时进行干预、减少住院时间并提高患者满意度。此外，对 ASC 基础设施的投资不断增加以及门诊网路的不断扩大正在推动市场成长。

在快速城市化、不断增加的医疗保健支出和迅速增长的儿科人口的推动下，到 2032 年，亚太地区儿科导管市场将获得可观的估值。中国、印度和日本等国家的儿科医疗基础设施发展迅猛，同时也越来越重视预防性和治疗性儿科泌尿外科干预措施。此外，旨在改善儿科医疗保健取得和负担能力的有利政府措施进一步推动了该地区的市场成长。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 泌尿系统疾病盛行率增加
    • 导管设计的技术进步
    • 全球儿科人口不断增加
    • 儿童微创外科手术的需求不断增长
  • 产业陷阱与挑战
    • 关于导管相关併发症的担忧
    • 儿科导尿管成本高
• 成长潜力分析
• 监管环境
• 技术景观
• 波特的分析
• PESTEL分析
• 定价分析
• 未来市场趋势
• 缺口分析

第 4 章：竞争格局

• 介绍
• 公司矩阵分析
• 公司市占率分析
• 竞争定位矩阵
• 战略仪表板

第 5 章：市场估计与预测：按产品类型，2018 年 - 2032 年

• 主要趋势
• 心血管导管
• 泌尿科导管
• 静脉导管
• 神经血管导管
• 特种导管

第 6 章：市场估计与预测：按材料划分，2018 - 2032 年

• 主要趋势
• 聚氯乙烯
• 硅酮
• 聚氨酯
• 乳胶
• 其他材料

第 7 章：市场估计与预测：按最终用途，2018 - 2032 年

• 主要趋势
• 医院
• 专科诊所
• 门诊手术中心
• 其他最终用户

第 8 章：市场估计与预测：按地区划分，2018 年 - 2032 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地区
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋
  • 中东和非洲其他地区

第 9 章：公司简介

• Becton, Dickinson and Company
• Boston Scientific Corporation
• Coloplast Corp
• Cook Medical
• Edwards Lifesciences Corporation
• Getinge AB
• ICU Medical, Inc.
• Johnson & Johnson Private Limited
• Medline Industries, LP
• Medtronic, Plc.

Global Pediatric Catheters Market will grow at 7.1% CAGR during 2024-2032, driven by technological innovations in catheter design, growing demand for minimally invasive procedures, increasing healthcare expenditure, and rising awareness about pediatric healthcare.

The increasing prevalence of pediatric urological disorders, such as urinary tract infections (UTIs), vesicoureteral reflux (VUR), and neurogenic bladder dysfunction, is a significant driver of growth in the pediatric catheters market.

According to BMC Infectious Diseases, UTIs rank as the second most prevalent infectious disease worldwide, impacting over 150 million individuals annually. UTIs, characterized by bacterial infection in the urinary tract, necessitate prompt diagnosis and treatment to prevent complications, with catheterization commonly employed for urine sample collection and medication administration.

Similarly, neurogenic bladder dysfunction, resulting from neurological conditions, mandates regular catheterization to prevent urinary retention and associated complications. The rising demand for pediatric catheters reflects the increasing need for effective diagnostic and therapeutic interventions in pediatric urology, prompting manufacturers to innovate and develop tailored catheter solutions to meet the unique requirements of pediatric patients.

The Pediatric Catheters Market is classified based on product type, material, end-use, and region.

The urology catheters segment will amass appreciable gains over 2024-2032, owing to their widespread use in the diagnosis and treatment of various pediatric urological conditions. Urology catheters, including Foley catheters, intermittent catheters, and external catheters, play a vital role in managing urinary retention, incontinence, and bladder dysfunction in pediatric patients. The continuous innovation in urology catheter designs, such as hydrophilic coatings, antimicrobial properties, and pediatric-specific sizes, is further driving expansion.

Ambulatory surgical centers (ASCs) segment will capture a modest pediatric catheters market share by 2032, driven by the increasing preference for outpatient procedures and the growing focus on cost-effective healthcare delivery models. ASCs offer a convenient and efficient setting for pediatric catheterization procedures, enabling timely interventions, reduced hospital stays, and enhanced patient satisfaction. Moreover, the rising investments in ASC infrastructure and the expanding network of outpatient clinics are bolstering market growth.

Asia Pacific Pediatric Catheters Market will garner a decent valuation by 2032, fueled by rapid urbanization, increasing healthcare expenditure, and a burgeoning pediatric population. Countries such as China, India, and Japan are witnessing a surge in pediatric healthcare infrastructure development, coupled with a growing emphasis on preventive and therapeutic pediatric urology interventions. Moreover, favorable government initiatives aimed at improving pediatric healthcare access and affordability are further propelling market growth in the region.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Base estimates & calculations
• 1.3 Data collection
• 1.4 Forecast calculations
• 1.5 Data validation
• 1.6 Data sources
  • 1.6.1 Primary
  • 1.6.2 Secondary
    • 1.6.2.1 Paid sources
    • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

• 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of urological disorders
    • 3.2.1.2 Technological advancements in catheter design
    • 3.2.1.3 Rising pediatric population globally
    • 3.2.1.4 Growing demand for minimally invasive surgical procedures in pediatrics
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Concerns regarding catheter-associated complications
    • 3.2.2.2 High cost of pediatric catheters
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Porter's analysis
  • 3.6.1 Supplier power
  • 3.6.2 Buyer power
  • 3.6.3 Threat of new entrants
  • 3.6.4 Threat of substitutes
  • 3.6.5 Industry rivalry
• 3.7 PESTEL analysis
• 3.8 Pricing analysis
• 3.9 Future market trends
• 3.10 Gap analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2018 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Cardiovascular catheters
• 5.3 Urology catheters
• 5.4 Intravenous catheters
• 5.5 Neurovascular catheters
• 5.6 Specialty catheters

Chapter 6 Market Estimates and Forecast, By Material, 2018 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Polyvinyl chloride
• 6.3 Silicone
• 6.4 Polyurethane
• 6.5 Latex
• 6.6 Other materials

Chapter 7 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Specialty clinics
• 7.4 Ambulatory surgical centers
• 7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Italy
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Becton, Dickinson and Company
• 9.2 Boston Scientific Corporation
• 9.3 Coloplast Corp
• 9.4 Cook Medical
• 9.5 Edwards Lifesciences Corporation
• 9.6 Getinge AB
• 9.7 ICU Medical, Inc.
• 9.8 Johnson & Johnson Private Limited
• 9.9 Medline Industries, LP
• 9.10 Medtronic, Plc.